salient topic, and services in the field are certainly not as available to people as they would like. People are also used to making increasingly more decisions about their health themselves, and they are quite well-informed. Today people tend to try to take the initiative themselves as the first step toward understanding what the problem is and how it might be treated. Democracy in healthcare and patient autonomy will be the next big drivers of developments in the healthcare sector and Selfdiagnostics is committed to supporting these values.

Selfdiagnostics is introducing to market a patient-side diagnostic concept and solution to allow for an additional capability for diagnosing patients at home with the goal of starting treatment as early as possible. Doing so we have developed a unique molecular diagnostics platform for medical point of care devices from which our first product STD Multitest to detect sexually transmitted diseases is ready to scale up production and start world wide sales.

Our proprietary technology allows to diversify portfolio of different DNA and RNA detection purposes like for respiratory (Influenza, TB), blood born (HIV, Hepatitis) and urine (CT, NG, MG, TV, Zika) based diseases. We are pioneer of next generation molecular diagnostics solution bringing Nobel-Prize winning PCR (polymerase chain reaction) medical tests straight to patients.